Centre for Genetics and Genomics Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Dermatology Centre, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchester, UK.
BMC Biol. 2020 May 4;18(1):47. doi: 10.1186/s12915-020-00779-3.
Genome-wide association studies (GWAS) have uncovered many genetic risk loci for psoriasis, yet many remain uncharacterised in terms of the causal gene and their biological mechanism in disease. This is largely a result of the findings that over 90% of GWAS variants map outside of protein-coding DNA and instead are enriched in cell type- and stimulation-specific gene regulatory regions.
Here, we use a disease-focused Capture Hi-C (CHi-C) experiment to link psoriasis-associated variants with their target genes in psoriasis-relevant cell lines (HaCaT keratinocytes and My-La CD8+ T cells). We confirm previously assigned genes, suggest novel candidates and provide evidence for complexity at psoriasis GWAS loci. For one locus, uniquely, we combine further epigenomic evidence to demonstrate how a psoriasis-associated region forms a functional interaction with the distant (> 500 kb) KLF4 gene. This interaction occurs between the gene and active enhancers in HaCaT cells, but not in My-La cells. We go on to investigate this long-distance interaction further with Cas9 fusion protein-mediated chromatin modification (CRISPR activation) coupled with RNA-seq, demonstrating how activation of the psoriasis-associated enhancer upregulates KLF4 and its downstream targets, relevant to skin cells and apoptosis.
This approach utilises multiple functional genomic techniques to follow up GWAS-associated variants implicating relevant cell types and causal genes in each locus; these are vital next steps for the translation of genetic findings into clinical benefit.
全基因组关联研究(GWAS)已经发现了许多银屑病的遗传风险基因座,但就致病基因及其在疾病中的生物学机制而言,其中许多仍未得到阐明。这主要是因为发现超过 90%的 GWAS 变异位于蛋白质编码 DNA 之外,而是富集在细胞类型和刺激特异性基因调控区域。
在这里,我们使用疾病特异性捕获 Hi-C(CHi-C)实验将银屑病相关变体与其在银屑病相关细胞系(HaCaT 角质形成细胞和 My-La CD8+T 细胞)中的靶基因联系起来。我们证实了先前分配的基因,提出了新的候选基因,并为银屑病 GWAS 基因座的复杂性提供了证据。对于一个独特的基因座,我们结合进一步的表观基因组证据来证明银屑病相关区域如何与远处(>500kb)KLF4 基因形成功能相互作用。这种相互作用发生在 HaCaT 细胞中的基因和活性增强子之间,但不在 My-La 细胞中。我们继续用 Cas9 融合蛋白介导的染色质修饰(CRISPR 激活)和 RNA-seq 进一步研究这种长距离相互作用,证明了银屑病相关增强子的激活如何上调 KLF4 及其下游靶基因,这些基因与皮肤细胞和细胞凋亡有关。
这种方法利用多种功能基因组技术来跟踪每个基因座中与相关细胞类型和致病基因相关的 GWAS 相关变体;这些是将遗传发现转化为临床益处的重要下一步。